Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: G
Results 181 - 190 of 306 shown below

  • gestational trophoblastic disease

    F Khan, J Everard, S Ahmed, R E Coleman, M Aitken and B W Hancock

    Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects

    doi:10.1038/sj.bjc.6601422

    Abstract | Full article | PDF

  • T Powles, P Savage, D Short, A Young, C Pappin and M J Seckl

    Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?

    advance online publication, 2005-12-13 00:00:00.000;

    doi:10.1038/sj.bjc.6602899

    Abstract | Full article | PDF

  • L S Dobson, P C Lorigan, R E Coleman and B W Hancock

    Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease

    doi:10.1054/bjoc.2000.1176

    Abstract | Full article | PDF

  • gestational trophoblastic neoplasia

    L M El-Helw, M J Seckl, R Haynes, L S Evans, P C Lorigan, J Long, E J Kanfer, E S Newlands and B W Hancock

    High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia

    advance online publication, 2005-09-06 00:00:00.000;

    doi:10.1038/sj.bjc.6602771

    Abstract | Full article | PDF

  • T Powles, P M Savage, J Stebbing, D Short, A Young, M Bower, C Pappin, P Schmid and M J Seckl

    A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia

    advance online publication, 2007-02-13 00:00:00.000;

    doi:10.1038/sj.bjc.6603608

    Abstract | Full article | PDF

  • GF120918

    A H van Hattum, I J Hoogsteen, H M M Schlüper, M Maliepaard, G L Scheffer, R J Scheper, G Kohlhagen, Y Pommier, H M Pinedo and E Boven

    Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity

    doi:10.1038/sj.bjc.6600508

    Abstract | Full article | PDF

  • H C L Traunecker, M C G Stevens, D J Kerr and D R Ferry

    The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells

    doi:10.1038/sj.bjc.6690791

    Abstract | Full article | PDF

  • M M Malingré, J H Beijnen, H Rosing, F J Koopman, R C Jewell, E M Paul, W W Ten Bokkel Huinink and J H M Schellens

    Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients

    doi:10.1054/bjoc.2000.1543

    Abstract | Full article | PDF

  • GFRalpha-1

    O Gimm, A Gössling, D J Marsh, P L M Dahia, L M Mulligan, A von Deimling and C Eng

    Mutation and deletion analysis of GFRalpha-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours

    doi:10.1038/sj.bjc.6690367

    Abstract | Full article | PDF

  • GG918 (formerly GF120918)

    A Wallstab, M Koester, M Böhme and D Keppler

    Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918

    doi:10.1038/sj.bjc.6690169

    Abstract | Full article | PDF

  • GH-RH antagonists

    K Szepeshazi, A V Schally, K Groot, P Armatis, G Halmos, F Hebert, B Szende, J L Varga and M Zarandi

    Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

    doi:10.1054/bjoc.2000.1223

    Abstract | Full article | PDF

  • ghrelin

    F Strasser, T A Lutz, M T Maeder, B Thuerlimann, D Bueche, M Tschöp, K Kaufmann, B Holst, M Brändle, R von Moos, R Demmer and T Cerny

    Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study

    advance online publication, 2008-01-08 00:00:00.000;

    doi:10.1038/sj.bjc.6604148

    Abstract | Full article | PDF

  • GHRH

    N Barabutis and A V Schally

    Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines

    advance online publication, 2008-05-27 00:00:00.000;

    doi:10.1038/sj.bjc.6604386

    Abstract | Full article | PDF

  • GIST

    T Simonsson, K Sjölund, P Bümming, H Ahlman, B Nilsson and A Odén

    Reducing uncertainty in health-care resource allocation

    advance online publication, 2007-05-22 00:00:00.000;

    doi:10.1038/sj.bjc.6603795

    Abstract | Full article | PDF

  • J-B Bachet, I Hostein, A Le Cesne, S Brahimi, A Beauchet, S Tabone-Eglinger, F Subra, B Bui, F Duffaud, P Terrier, J-M Coindre, J-Y Blay and J-F Emile

    Prognosis and predictive value of KIT exon 11 deletion in GISTs

    advance online publication, 2009-06-16 00:00:00.000;

    doi:10.1038/sj.bjc.6605117

    Abstract | Full article | PDF

  • Gl/S transition

    Y Hedberg, B Ljungberg, G Roos and G Landberg

    Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray

    doi:10.1038/sj.bjc.6600922

    Abstract | Full article | PDF